Study Stopped
IRB closed
MS and NMOSD in African-Americans
1 other identifier
observational
N/A
1 country
1
Brief Summary
This is a prospective study that aims to collect and review neuromyelitis optica spectrum disorder (NMOSD) data from African American patients with a known diagnosis of multiple sclerosis (MS). It is an investigational study, prospective in nature. No randomization of patients will be done. Information collected includes: Age, gender, age at diagnosis, MRI data (access to images), clinical presentation, findings on clinical examination, lab (blood and evoked potentials) and LP test results, eye exam findings if any and treatment, if started. Additional details may include other NEUROLOGICAL diseases which are also diagnosed (if any).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jul 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 5, 2019
CompletedFirst Submitted
Initial submission to the registry
October 14, 2019
CompletedFirst Posted
Study publicly available on registry
October 18, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedNovember 14, 2022
November 1, 2022
4.5 years
October 14, 2019
November 9, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Clinical data collection and comparison
Collect patient age, sex, date of birth, and date of diagnosis to examine trends among this population.
Through study completion, average duration of four years
Secondary Outcomes (2)
MRI analysis
Through study completion, average duration of four years
Diagnostic tests collection and comparison
Through study completion, average duration of four years
Study Arms (1)
African Americans with MS
African American patients seen in the University of Kentucky's Multiple Sclerosis Clinic between the ages of 18 and 80 who have been diagnosed with MS
Eligibility Criteria
African American patients who have been diagnosed with MS and later diagnosed as having NMOSD. They will be patients that have been seen in the Kentucky Neuroscience Institute (KNI). The age range will be 18-80.
You may qualify if:
- between the ages of 18 and 80
- are African-American
- have a diagnosis of MS and later diagnosis of NMOSD
- have been seen at the University of Kentucky's Kentucky Neuroscience Institute
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Kentucky
Lexington, Kentucky, 40536, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jagannadha Avasarala, MD PhD
University of Kentucky
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor of Neurology
Study Record Dates
First Submitted
October 14, 2019
First Posted
October 18, 2019
Study Start
July 5, 2019
Primary Completion
December 31, 2023
Study Completion
December 31, 2023
Last Updated
November 14, 2022
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will not share